Blood coagulation: a powerful bactericidal mechanism of human innate immunity

References

• Delvaeye M, Conway EM. Coagulation and innate immune responses: Can we view them separately? Blood 2009;114(12):2367–2374.
   PubMed Web of Science ®Google Scholar
• Loof TG, Mörgelin M, Johansson L, et al. Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood 2011;118(9):2589–2598.
   PubMed Web of Science ®Google Scholar
• Page MJ, Di Cera E. Serine peptidases: classification, structure and function. Cell Mol Life Sci 2008;65(7–8):1220–1226.
   PubMed Web of Science ®Google Scholar
• Schroeder V, Kohler HP. New developments in the area of factor XIII. J Thromb Haemost 2013; Feb; 11(2):234–244.
   PubMed Web of Science ®Google Scholar
• Dickneite G, Herwald H, Korte W, Allanore Y, Denton CP, Matucci Cerinic M. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions. Thromb Haemost 2015;113(04):686–697.
   PubMedGoogle Scholar
• Wang Z, Wilhelmsson C, Hyrsl P. Pathogen entrapment by transglutaminase—a conserved early innate immune mechanism. PLoS Pathog 2010;6(2):e1000763
   PubMed Web of Science ®Google Scholar
• Armstrong MT, Rickles FR, Armstrong PB. Capture of lipopolysaccharide (endotoxin) by the blood clot: a comparative study. PLoS One 2013;8(11):e80192
   PubMed Web of Science ®Google Scholar
• Cines DB, Lebedeva T, Nagaswami C, et al. Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. Blood 2014;123(10):1596–1603. doi: 10.1182/blood-2013-08-523860
   PubMed Web of Science ®Google Scholar
• Kasahara K, Kaneda M, Miki T, et al. Clot retraction is mediated by factor XIII-dependent fibrin-αIIbβ3-myosin axis in platelet sphingomyelin-rich membrane rafts. Blood 2013;122(19):3340–3348.
   PubMed Web of Science ®Google Scholar
• Jen CJ, McIntire LV. The structural properties and contractile force of a clot. Cell Motil 1982;2(5):445–455.
   PubMedGoogle Scholar
• Carr ME. Jr., Development of platelet contractile force as a research and clinical measure of platelet function. Cell Biochem Biophys 2003;38(1):55–78.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Trostel A, Le P, Harinarayanan R, Fitzgerald PC, Adhya S. Cellular stress created by intermediary metabolite imbalances. Proc Natl Acad Sci USA 2009;106(46):19515–19520.
   PubMed Web of Science ®Google Scholar
• Ray JCJ, Wickersheim ML, Jalihal AP, Adeshina YO, Cooper TF, Balázsi G. Cellular GrowthArrestandPersistencefromEnzyme Saturation. PLoS Comput Biol 2016;12(3):e1004825. doi: 10.1371/journal.pcbi.1004825
   PubMed Web of Science ®Google Scholar
• Konopka A, Furbacher P, Gedney C. Introduction to microbiology. London: Pearson Education Limited. 2003.
   Google Scholar
• Lehman D. Introduction to Microbiology. Dubuque, Iowa: Kendall Hunt Pub Co; 2003.
   Google Scholar
• Wilson M, Mcnab R, Henderson B. Bacterial disease mechanisms: An introduction to cellular microbiology. Cambridge: Cambridge University Press; 2002.
   Google Scholar
• Sun H. The interaction between pathogens and the host coagulation system. Physiology (Bethesda) 2006; Aug; 21:281–288.
   PubMed Web of Science ®Google Scholar
• Travis J, Potempa J. Bacterial proteinases as targets for the development of second-generation antibiotics. Biochim Biophys Acta 2000;1477(1–2):35–50.
   PubMed Web of Science ®Google Scholar
• Oleksy A, Golonka E, Bańbuła A, et al. Growth phase-dependent production of a cell wall-associated elastinolytic cysteine proteinase by Staphylococcus epidermidis. Biol Chem 2004;385(6):525–535.
   PubMed Web of Science ®Google Scholar
• Harris TO, Shelver DW, Bohnsack JF, Rubens CE. A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J Clin Invest 2003;111(1):61–70.
   PubMed Web of Science ®Google Scholar
• Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005;3(8):1894–1904.
   PubMed Web of Science ®Google Scholar
• Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev 2007;21(3):131–142.
   PubMed Web of Science ®Google Scholar
• Collet JP, Moen JL, Veklich YI, et al. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. Blood 2005;106(12):3824–3830.
   PubMed Web of Science ®Google Scholar
• Weisel JW, Medved L. The structure and function of the alpha C domains of fibrinogen. Ann N Y Acad Sci 2001;936:312–327.
   PubMed Web of Science ®Google Scholar
• Si F, Li B, Margolin W, Sun SX. Bacterial growth and form under mechanical compression. Sci Rep 2015;5:11367art.no.
   PubMed Web of Science ®Google Scholar
• Jiang HY, Sun SX. Morphology, growth, and size limit of bacterial cells. Phys Rev Lett 2010;105(2):028101
   PubMed Web of Science ®Google Scholar
• Kumar P, Libchaber A. Pressure and temperature dependence of growth and morphology of Escherichia coli: experiments and stochastic model. Biophys J 2013;105(3):783–793.
   PubMed Web of Science ®Google Scholar
• Zhou X, Halladin DK, Rojas ER, et al. Bacterial division. Mechanical crack propagation drives millisecond daughter cell separation in Staphylococcus aureus. Science 2015;348(6234):574–578. ()
   PubMed Web of Science ®Google Scholar
• Potts M. Desiccation tolerance of prokaryotes. Microbiol Rev 1994;58(4):755–805.
   PubMedGoogle Scholar
• Klinger MHF, Ulbricht T. Participation of human blood platelets in antimicrobial host defense. Transfus Med Hemother 2003;30(2):57–62.
   Web of Science ®Google Scholar
• Dankert J, vanDer Werff J, Zaat SAJ, Joldersma W, Klein D, Hess J. Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Inf Immun 1995;63(2):663–671.
   PubMed Web of Science ®Google Scholar
• Moojen DJ, Everts PA, Schure RM, et al. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res 2008;26(3):404–410. :
   PubMed Web of Science ®Google Scholar
• Trowbridge CC, Stammers AH, Woods E, Yen BR, Klayman M, Gilbert C. Use of platelet gel and its effects on infection in cardiac surgery. J Extra Corpor Technol 2005;37(4):381–386.
   PubMedGoogle Scholar
• Ali RA, Wuescher LM, Keith R, Dona KR, Worth RG. Platelets mediate host defense against staphylococcus aureus through direct bactericidal activity and by enhancing macrophage activities. JI 2017;198(1):344–351.
   Google Scholar
• Yeaman MR. The role of platelets in antimicrobial host defense. Clin Infect Dis 1997;25(5):951–968.
   PubMed Web of Science ®Google Scholar
• Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 2002;22(9):913–922.
   PubMed Web of Science ®Google Scholar
• Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun 2002;70(12):6524–6533.
   PubMed Web of Science ®Google Scholar
• Semple JW, Italiano JE, Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011;11(4):264–274.
   PubMed Web of Science ®Google Scholar
• Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007;13(4):463–469.
   PubMed Web of Science ®Google Scholar
• Costanzo LS. Physiology. Hagerstown, Maryland: Lippincott Williams & Wilkins. 2007.
   Google Scholar
• Minasyan H. Erythrocyte and blood antibacterial defense. Eur J Microbiol Immunol (Bp) 2014;4(2):138–233.
   PubMedGoogle Scholar
• Minasyan H. Mechanisms and pathways for the clearance of bacteria from blood circulation in health and disease. Pathophysiology 2016;23:61–66.
   PubMedGoogle Scholar
• Hodson D, Hirsch JG. The antibacterial activity of hemoglobin. J Exp Med 1958;107(2):167–183.
   PubMed Web of Science ®Google Scholar
• Sheshadri P, Abraham J. Antimicrobial properties of hemoglobin. Immunopharmacol Immunotoxicol 2012;34(6):896–900.
   PubMed Web of Science ®Google Scholar
• Mak P, Wójcik K, Silberring J, Dubin A. Antimicrobial peptides derived from heme-containing proteins: Hemocidins. Antonie Van Leeuwenhoek 2000;77(3):197
   PubMed Web of Science ®Google Scholar
• Mak P. Hemocidins in a functional and structural context of human antimicrobial peptides. Front Biosci 2008;13:6859–6871.
   PubMed Web of Science ®Google Scholar
• Liepke C, Baxmann S, Heine C, Breithaupt N, Ständker L, Forssmann WG. J Human hemoglobin-derived peptides exhibit antimicrobial activity: a class of host defense peptides. Chromatogr B Analyt Technol Biomed Life Sci 2003;791(1-2):345–356.
   PubMed Web of Science ®Google Scholar
• Pichereau V, Hartke A, Auffray Y. Starvation and osmotic stress induced multiresistances: influence. of Extracellular Compounds. Int J Food Microbiol 2000;55(1-3):19–25.
   PubMed Web of Science ®Google Scholar
• Csonka LN. Physiological and genetic responses of bacteria to osmotic stress. Microbiol Rev 1989; 53(1):121–147.
   PubMedGoogle Scholar
• Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterr J Hematol Infect Dis 2010;132(3):e2010024
   PubMedGoogle Scholar
• Wada H, Matsumoto T, Yamashita Y. Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care 2014;2(1):1520
   PubMedGoogle Scholar
• Kälsch T, Elmas E, Nguyen XD, et al. Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation. Basic Res Cardiol 2007; 102(5):460–466.
   PubMed Web of Science ®Google Scholar
• Levi M, Schultz M, van der Poll T. Sepsis and thrombosis. Semin Thromb Hemost 2013;39(5):559–566.
   PubMed Web of Science ®Google Scholar
• Venugopal A. Disseminated intravascular coagulation. Indian J Anaesth 2014; Sep58(5):603–608.
   PubMedGoogle Scholar
• Davis RP, Miller-Dorey S, Jenne CN. Platelets and coagulation in infection. Clin Transl Immunol 2016;85(7):e89
   PubMedGoogle Scholar
• Freeman BD, Buchman TG. Coagulation inhibitors in the treatment of sepsis. Expert Opin Investig Drugs 2002;11(1):69–74.
   PubMed Web of Science ®Google Scholar
• Griffin JH, Fernandez JA, Gale AJ, Mosnier LO. Activated protein C. J Thromb Haemost 2007;5(1):73–80.
   PubMedGoogle Scholar
• Fourrier F, Chopin C, Goudemand J, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992;101(3):816–823.
   PubMed Web of Science ®Google Scholar
• Levi M, van der Poll T. Recombinant human activated protein C: current insights into its mechanism of action. Crit Care 2007;11(Suppl 5):S3.
   PubMedGoogle Scholar
• Bernard GR, Ely EW, Wright TJ. Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Crit Care Med 2001;29(11):2051–2059.
   PubMed Web of Science ®Google Scholar
• Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344(10):699–709.
   PubMed Web of Science ®Google Scholar
• Fumagalli R, Mignini MA. The risk profile of drotrecogin alfa (activated). Crit Care 2007;11(Suppl 5):S6–S6.
   PubMedGoogle Scholar
• Ely EW, Laterre P-F, Angus DC, et al. Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med 2003;31(1):12–19.
   PubMed Web of Science ®Google Scholar
• Abraham E, Laterre PF, Garg R, et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005;353(13):1332–1341.
   PubMed Web of Science ®Google Scholar
• Nadel S, Goldstein B, Williams MD, et al. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet 2007;369(9564):836–843.
   PubMed Web of Science ®Google Scholar
• Carlet J. Prescribing indications based on successful clinical trials in sepsis: a difficult exercise. Crit Care Med 2006;34(2):525–529.
   PubMed Web of Science ®Google Scholar
• Ranieri VM, Thompson BT, Barie PS, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012;366(22):2055–2064.
   PubMed Web of Science ®Google Scholar
• Fourrier F, Jourdain M, Tournoys A. Clinical trial results with antithrombin III in sepsis. Crit Care Med 2000;28(9 Suppl):S38–S43.
   PubMed Web of Science ®Google Scholar
• Allingstrup M, Wetterslev J, Ravn FB, Møller AM, Afshari A. Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis. Systematic Review. Intensive Care Med 2016;42(4):505–520.
   PubMed Web of Science ®Google Scholar
• Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost 2006;32(1):32–38.
   PubMedGoogle Scholar
• Mousa SA, Fareed J, Iqbal O, Kaiser B. Tissue factor pathway inhibitor in thrombosis and beyond. Methods Mol Med. 2004;93:133–155.
   Google Scholar
• Broze GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VIIa-tissue factor complex, also inhibits factor Xa: insight into its possible mechanism of action. Blood 1988;71:335–343.
   PubMed Web of Science ®Google Scholar
• Sandset PM, Abildgaard U, Larsen ML. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res 1988;50(6):803–813.
   PubMed Web of Science ®Google Scholar
• Fareed J, Hoppensteadt D, Jeske W, Clarizio R, Walenga JM. Low molecular weight heparins. Are They Different? Can J Cardiol 1998;14:28–34.
   Google Scholar
• Liu XIAO-LI, Wang XIAO-ZHI, Liu XIU-XIANG, et al. Low-dose heparin as treatment for early disseminated intravascular coagulation during sepsis: A prospective clinical study. Exp Therap Med 2014;7(3):604–608., ().
   PubMed Web of Science ®Google Scholar
• Shen JI, Winkelmayer WC. Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis. Am J Kidney Dis 2012;60(3):473–486.
   PubMed Web of Science ®Google Scholar
• Zarychanski R, Abou-Setta AM, Kanji S, et al. Heparin in patients with sepsis, septic shock, and disseminated intravascular coagulation associated with infection may be associated with decreased mortality. Crit Care Med 2015;43(3):511–518.
   PubMed Web of Science ®Google Scholar
• Umemura Y, Yamakawa K, Ogura H, Yuhara H, Fujimi SJ. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost 2016;14(3):518–530.
   PubMed Web of Science ®Google Scholar
• Zhao C, Zhang ZD, Zhang XJ, Li X, Zhu R, Ma XC. Evaluation of clinical effects on low-dose heparin therapy for sepsis. Zhonghua Nei Ke Za Zhi 2009;48(7):566–569.
   PubMedGoogle Scholar
• Wang C, Chi C, Guo L, et al. Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis. Crit Care 2014;18(5):563.
   PubMed Web of Science ®Google Scholar
• Yang CH, Guan XD, Chen J, et al. The study of the mechanism of the effect of heparin on tissue perfusion of sepsis patients. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2008;20(9):550–552.
   PubMedGoogle Scholar
• Liu Z, Zhu H, Ma X. Heparin for treatment of sepsis: a systemic review. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2014;26(3):135–141.
   PubMedGoogle Scholar
• Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009;145(1):24–33. Apr
   PubMed Web of Science ®Google Scholar
• Wada H, Thachil J, Di Nisio M, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost 2013; doi: 10.1111/jth.12155. [Epub ahead of print]
   Google Scholar
• Norberg B, Bandmann U, Rydgren L. Amoeboid movement in human leucocytes: basic mechanisms, cytobiological and clinical significance. J Mechanochem Cell Motil 1977;4(1):37–53.
   PubMedGoogle Scholar
• Jacob M, Chappell D, Rehm M. The 'third space'-fact or fiction? Best Pract Res Clin Anaesthesiol 2009;23(2):145–157.
   PubMedGoogle Scholar
• Dorland N. Dorland's Illustrated Medical Dictionary (32nd ed.). Philadelphia, PA: Saunders/Elsevier; 2012.
   Google Scholar
• Wiig H, Swartz MA. Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol Rev 2012;92(3):1005–1060.
   PubMed Web of Science ®Google Scholar
• Yao W, Li Y, Ding G. Interstitial Fluid Flow: The Mechanical Environment of Cells and Foundation of Meridians. Evidence-Based Complementary and Alternative Medicine. Volume 2012 (2012), Article ID 853516
   Google Scholar
• Tarbell JM, Weinbaum S, Kamm RD. Cellular fluid mechanics and mechanotransduction. Ann Biomed Eng 2005;33(12):1719–1723.
   PubMed Web of Science ®Google Scholar
• Hillman RS, Ault KA, Rinder HM. Hematology in clinical practice: A guide to diagnosis and management (4th ed.). New York: McGraw-Hill Professional; 2005.
   Google Scholar
• Pierigè F, Serafini S, Rossi L, Magnani M. Cell-based drug delivery. Adv Drug Deliv Rev 2008;60(2):286–385.
   PubMed Web of Science ®Google Scholar
• Marieb EN, Hoehn K. The cardiovascular system: blood vessels. Human anatomy & physiology, 10th ed. London: Pearson Education, Inc. 2016.
   Google Scholar
• Marieb EN, Hoehn K. The cardiovascular system: blood vessels. Human anatomy & physiology, 9th ed. London: Pearson Education Inc. 2013 p. 712.
   Google Scholar
• Lee C-Y, Herant M, Heinrich V. Target-specific mechanics of phagocytosis: protrusive neutrophil response to zymosan differs from the uptake of antibody-tagged pathogens. J Cell Sci 2011;124(Pt 7):1106–1108.
   PubMed Web of Science ®Google Scholar
• Herant M, Heinrich V, Dembo M. Mechanics of neutrophil phagocytosis: experiments and quantitative models. J Cell Sci 2006;119(Pt 9):1903–1913.
   PubMed Web of Science ®Google Scholar
• Minasyan H. Phagocytosis and oxycytosis: two arms of human innate immunity. Immunol Res 2018;66(2):271–280.
   PubMed Web of Science ®Google Scholar
• Huntington JA. Natural inhibitors of thrombin. Thromb Haemost 2014;111(4):583–589.
   PubMed Web of Science ®Google Scholar
• Beaulieu LM, Freedman JE. The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes. Thromb Res 2010;125(3):205–209.
   PubMed Web of Science ®Google Scholar
• Hamzeh-Cognasse H, Damien P, Chabert A, Pozzetto B, Cognasse F, Garraud O. Platelets and infections—complex interactions with bacteria. Front Immunol 2015;6:82.
   PubMed Web of Science ®Google Scholar
• Arman M, Krauel K, Tilley DO, et al. Amplification of bacteria-induced platelet activation is triggered by FcγRIIA, integrin αIIbβ3, and platelet factor 4. Blood 2014;123(20):3166–3174.
   PubMed Web of Science ®Google Scholar
• Loof TG, Deicke C, Medina E. The role of coagulation/fibrinolysis during Streptococcus pyogenes infection. Front Cellular Infect Microbiol 2014;4:128.
   PubMed Web of Science ®Google Scholar
• Itoh S, Yokoyama R, Kamoshida G, et al. Staphylococcal superantigen-like protein 10 (SSL10) inhibits blood coagulation by binding to prothrombin and factor Xa via their γ-carboxyglutamic acid (Gla) domain. J Biol Chem 2013;288(30):21569–21580.
   PubMed Web of Science ®Google Scholar
• Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S. Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 2000;28(2):451–457.
   PubMed Web of Science ®Google Scholar
• Thomer L, Schneewind O, Missiakas D. Multiple ligands of von Willebrand factor-binding protein (vWbp) promote Staphylococcus aureus clot formation in human plasma. J Biol Chem 2013;288(39):28283–28292.
   PubMed Web of Science ®Google Scholar
• Berends ETM, Kuipers A, Ravesloot MM, Urbanus RT, Rooijakkers SHM. Bacteria under stress by complement and coagulation. FEMS Microbiol Rev 2014;38(6):1146–1171.
   PubMed Web of Science ®Google Scholar
• Wallis R, Mitchell DA, Schmid R, Schwaeble WJ, Keeble AH. Paths reunited: Initiation of the classical and lectin pathways of complement activation. Immunobiology 2010;215(1):1–11.
   PubMed Web of Science ®Google Scholar
• Remy KE, Qiu P, Li Y, Cui X, Eichacker PQ. B. anthracis associated cardiovascular dysfunction and shock: the potential contribution of both non-toxin and toxin components. BMC Med 2013;11:217–219.
   PubMed Web of Science ®Google Scholar
• Barnum SR. Complement: A primer for the coming therapeutic revolution. Pharmacol Ther 2017; Dec 1. pii: 172(16):63–66.
   PubMedGoogle Scholar
• Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010;11(9):785–797.
   PubMed Web of Science ®Google Scholar
• Ghebrehiwet B. The complement system: an evolution in progress. F1000Res 2016;5:2840
   PubMedGoogle Scholar
• Parente R, Clark SJ, Inforzato A, Day AJ. Complement factor H in host defense and immune evasion. Cell Mol Life Sci 2017;74(9):1605–1624.
   PubMed Web of Science ®Google Scholar
• Meri T, Amdahl H, Lehtinen MJ, et al. Microbes bind complement inhibitor factor H via a common site. PLoS Pathog 2013;9(4):e1003308
   PubMed Web of Science ®Google Scholar
• Amdahl H, Jongerius I, Meri T, et al. Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion. J Immunol 2013;191(4):1775–1784. Aug 15;
   PubMed Web of Science ®Google Scholar
• Agarwal V, Sroka M, Fulde M, Bergmann S, Riesbeck K, Blom A. Binding of Streptococcus pneumoniae endopeptidase O (PepO) to complement component C1q modulates the complement attack and promotes host cell adherence. J Biol Chem 2014;289(22):15833–15844.
   PubMed Web of Science ®Google Scholar
• Kang M, Ko Y-P, Liang X, et al. Collagen-binding microbial surface components recognizing adhesive matrix molecule (MSCRAMM) of Gram-positive bacteria inhibit complement activation via the classical pathway. J Biol Chem 2013;288(28):20520–20531.
   PubMed Web of Science ®Google Scholar
• Chung MC, Tonry JH, Narayanan A, et al. Bacillus anthracis interacts with plasmin(ogen) to evade C3b-dependent innate immunity. PLoS One 2011;6(3):e18119.
   PubMed Web of Science ®Google Scholar
• Jusko M, Potempa J, Kantyka T, et al. Staphylococcal proteases aid in evasion of the human complement system. J Innate Immun 2014;6(1):31–46.
   PubMed Web of Science ®Google Scholar
• Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol 2013;14(10):986–995.
   PubMed Web of Science ®Google Scholar
• Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000;164(12):6166–6173.
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140(6):805–820.
   PubMed Web of Science ®Google Scholar
• Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999;17:593–623.
   PubMed Web of Science ®Google Scholar
• Kim DC, Luster AD. The role of tissue resident cells in neutrophil recruitment. Trends Immunol 2015;36(9):547–555.
   PubMed Web of Science ®Google Scholar
• Cox D, Kerrigan SW, Watson SP. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost 2011;9(6):1097–1107.
   PubMed Web of Science ®Google Scholar
• Vicsek T, Zafeiris A. Collective Motion. Phys Rep 2012;517(3-4):71.
   Web of Science ®Google Scholar
• Dombrowski C, Cisneros L, Chatkaew S, Goldstein RE, Kessler JO. Self-concentration and large-scale coherence in bacterial dynamics. Phys Rev Lett 2004;93(9):098103
   PubMed Web of Science ®Google Scholar
• Borregaard N. Neutrophils, from marrow to microbes. Immunity 2010;33(5):657–670.
   PubMed Web of Science ®Google Scholar
• Yipp BG, Petri B, Salina D, et al. Infection-induced NETosis is a dynamic process involving NEUTROPHIL MULTITASKING IN VIVO. Nat Med 2012;18(9):1386–1393.
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004;303(5663):1532–1535. 03-05;AAAS.
   PubMed Web of Science ®Google Scholar
• Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood 2014;123(18):2768–2776.
   PubMed Web of Science ®Google Scholar
• Bayer AS, Ramos MD, Menzies BE, Yeaman MR, Shen AJ, Cheung AL. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect Immun 1997;65(11):4652–4660.
   PubMed Web of Science ®Google Scholar
• Bryant AE, Bayer CR, Chen RY, Guth PH, Wallace RJ, Stevens DL. Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: the role of streptolysin O-induced platelet/neutrophil complexes. J Infect Dis 2005;192(6):1014–1022.
   PubMed Web of Science ®Google Scholar
• Brauckmann S, Effenberger-Neidnicht K, de Groot H, et al. Lipopolysaccharide-induced hemolysis: Evidence for direct membrane interactions. Sci Rep 2016;6:35508.
   PubMed Web of Science ®Google Scholar
• Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005;293(13):1653–1662.
   PubMed Web of Science ®Google Scholar
• Misztal T, Tomasiak M. Pathophysiological consequences of hemolysis. Role of cell-free hemoglobin. Postepy Hig Med Dosw 2011;65:627–639.
   Web of Science ®Google Scholar
• Lin T, Kwak YH, Sammy F, et al. Synergistic inflammation is induced by blood degradation products with microbial toll-like receptor agonists and is blocked by hemopexin. J Infect Dis 2010;202(4):624–632.
   PubMed Web of Science ®Google Scholar
• Dutra FF, Alves LS, Rodrigues D, et al. Hemolysis-induced lethality involves inflammasome activation by heme. Proc Natl Acad Sci USA 2014;111(39):E4110–E4118.
   PubMed Web of Science ®Google Scholar
• Hvidberg V, Maniecki MB, Jacobsen C, Højrup P, Møller HJ, Moestrup SK. Identification of the receptor scavenging hemopexin-heme complexes. Blood 2005;106(7):2572–2579.
   PubMed Web of Science ®Google Scholar
• Janz DR, Bastarache JA, Peterson JF, et al. Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: an observational study. Crit Care Med 2013;41(3):784–790.
   PubMed Web of Science ®Google Scholar
• Adamzik M, Hamburger T, Petrat F, Peters J, de Groot H, Hartmann M. Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome. Crit Care 2012;16(4):R125
   PubMed Web of Science ®Google Scholar
• Larsen R, Gozzelino R, Jeney V, et al. Soares MP A central role for free heme in the pathogenesis of severe sepsis. Sci Transl Med 2010;2(51):51–71.,
   Web of Science ®Google Scholar
• Lin T, Maita D, Thundivalappil SR, et al. Hemopexin in severe inflammation and infection: mouse models and human diseases. Crit Care 2015;19:166.
   PubMed Web of Science ®Google Scholar
• Vinchi F, De Franceschi L, Ghigo A, et al. Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases. Circulation 2013;127(12):1317–1329.
   PubMed Web of Science ®Google Scholar
• Speth C, Löffler J, Krappmann S, Lass-Flörl C, Rambach G. Platelets as Immune Cells in Infectious Diseases. Future Microbiol 2013;8(11):1431–1451.
   PubMed Web of Science ®Google Scholar
• Kraemer BF, Campbell RA, Schwertz H, et al. Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets. Blood 2012;120(25):5014–5020.,.
   PubMed Web of Science ®Google Scholar
• Esmon CT. Interactions between the innate immune and blood coagulation systems. Trends Immunol2004;25(10):536–542.
   PubMed Web of Science ®Google Scholar
• Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013;13(1):34–45.
   PubMed Web of Science ®Google Scholar
• Ito T. PAMPs and DAMPs as triggers for DIC. J Intensive Care 2014;2(1):65.
   PubMedGoogle Scholar
• Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb Res 2012;129(3):290–295.
   PubMed Web of Science ®Google Scholar
• Lupu F, Keshari RS, Lambris JD, Coggeshall KM. Crosstalk between the coagulation and complement systems in sepsis. Thromb Res 2014;133(1):28–31.
   Google Scholar
• Muta T, Iwanaga S. The role of hemolymph coagulation in innate immunity. Curr Opin Immunol 1996;8(1):41–47.
   PubMed Web of Science ®Google Scholar
• Towhid ST, Nega M, Schmidt E-M, et al. Stimulation of platelet apoptosis by peptidoglycan from Staphylococcus aureus 113. Apoptosis 2012;17(9):998–1008.
   PubMed Web of Science ®Google Scholar
• Lee SP, Ataga KI, Orringer EP, Phillips DR, Parise LV. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation. Arterioscler Thromb Vasc Biol 2006;26(7):1626–1631.
   PubMed Web of Science ®Google Scholar
• Esmon CT. Molecular circuits in thrombosis and inflammation. Thromb Haemost 2013;109(3):416–420.
   PubMed Web of Science ®Google Scholar
• Stief TW. Thrombin generation by hemolysis. Blood Coagul Fibrinolysis 2007;18(1):61–66.
   PubMed Web of Science ®Google Scholar
• McDonald K, Cullinane AM, Merryman PK, Hoddeson EK. The effect of red blood cells on thrombin generation. Br J Haematol 2006;133(4):403–408.
   PubMed Web of Science ®Google Scholar
• Pfeiler S, Massberg S, Engelmann B. Biological basis and pathological relevance of microvascular thrombosis. Thromb Res 2014;133(Suppl 1):S35–S37.
   PubMedGoogle Scholar
• Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000;95(3):930–935. :
   PubMed Web of Science ®Google Scholar
• Bryant A. Biology and pathogenesis of thrombosis and procoagulant activity in invasive infections caused by group A streptococci and Clostridium perfringens. Clin Microbiol Rev 2003;16(3):451–462.
   PubMed Web of Science ®Google Scholar